Fingerprint
Dive into the research topics of 'A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma
E. Jonasch, E. Hasanov, P. G. Corn, T. Moss, K. R. Shaw, S. Stovall, V. Marcott, B. Gan, S. Bird, X. Wang, K. A. Do, P. F. Altamirano, A. J. Zurita, L. A. Doyle, P. N. Lara, N. M. Tannir
Research output: Contribution to journal › Article › peer-review
28
Scopus
citations